{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:20:45Z","timestamp":1777576845877,"version":"3.51.4"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2003,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Cattle may provide a suitable model for testing ways of improving tuberculosis vaccine efficacy in human infants. A vaccination and challenge study was undertaken in calves to determine the optimal time to vaccinate neonatal animals with<jats:italic>Mycobacterium bovis<\/jats:italic>bacillus Calmette-Gue\u0301rin (BCG) for protection against tuberculosis and to determine whether revaccination with BCG was beneficial. Calves (10 per group) were vaccinated with BCG within 8 h of birth or at 6 weeks of age, when immune responses to antigens of environmental mycobacteria were detectable, or vaccinated at birth and revaccinated at 6 weeks. A control group was not vaccinated. BCG vaccination at birth induced strong antigen-specific gamma interferon (IFN-\u03b3) and interleukin-2 (IL-2) responses and antigen-specific activation in CD4<jats:sup>+<\/jats:sup>, CD8<jats:sup>+<\/jats:sup>, and WC1<jats:sup>+<\/jats:sup>\u03b3\u03b4 T-cell subsets from blood. The proportions of animals per group with macroscopic tuberculous lesions after challenge were 0\/10 for BCG at birth, 1\/9 for BCG at 6 weeks, 4\/10 for the revaccinated group, and 10\/10 for the nonvaccinated group. There was no significant difference in the levels of protection between groups vaccinated at birth or at 6 weeks, while animals vaccinated both at birth and at 6 weeks had significantly less protection than those vaccinated only at birth. The revaccinated calves that subsequently developed tuberculous lesions had significantly stronger IFN-\u03b3 and IL-2 responses to bovine purified protein derivative after the BCG booster than those in the same group that did not develop lesions. The results indicated that BCG vaccination at birth induced a high level of immunity and that the sensitization of very young animals to antigens of environmental mycobacteria by 6 weeks of age did not affect the effectiveness of BCG. However, BCG revaccination of these young animals was contraindicated.<\/jats:p>","DOI":"10.1128\/iai.71.11.6411-6419.2003","type":"journal-article","created":{"date-parts":[[2003,10,24]],"date-time":"2003-10-24T02:31:56Z","timestamp":1066962716000},"page":"6411-6419","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":138,"title":["Revaccination of Neonatal Calves with<i>Mycobacterium bovis<\/i>BCG Reduces the Level of Protection against Bovine Tuberculosis Induced by a Single Vaccination"],"prefix":"10.1128","volume":"71","author":[{"given":"B. M.","family":"Buddle","sequence":"first","affiliation":[{"name":"AgResearch, Wallaceville Animal Research Centre, Upper Hutt, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. N.","family":"Wedlock","sequence":"additional","affiliation":[{"name":"AgResearch, Wallaceville Animal Research Centre, Upper Hutt, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. A.","family":"Parlane","sequence":"additional","affiliation":[{"name":"AgResearch, Wallaceville Animal Research Centre, Upper Hutt, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. A. L.","family":"Corner","sequence":"additional","affiliation":[{"name":"AgResearch, Wallaceville Animal Research Centre, Upper Hutt, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. W.","family":"de Lisle","sequence":"additional","affiliation":[{"name":"AgResearch, Wallaceville Animal Research Centre, Upper Hutt, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Skinner","sequence":"additional","affiliation":[{"name":"AgResearch, Wallaceville Animal Research Centre, Upper Hutt, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(01)01865-8"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830260713"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(97)01120-1"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Bloom B. R. and P. E. M. Fine. 1994. The BCG experience: implications for future vaccines against tuberculosis p 531-557. In B. R. Bloom (ed.) Tuberculosis: pathogenesis protection and control. American Society for Microbiology Washington D.C.","DOI":"10.1128\/9781555818357.ch31"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.2.672-678.2002"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)00055-R"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5288(95)90023-3"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00436-4"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7519(03)00060-2"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9975(98)80069-8"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830200415"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510330076038"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.96.1.29"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92348-9"},{"key":"e_1_3_2_16_2","first-page":"483","volume":"80","year":"2002","unstructured":"Ginsberg, A. M. 2002. What's new in tuberculosis vaccines? Bull. W. H. O.80:483-488.","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.3.2141"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1054\/tuld.1998.0202"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.4.1277"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","unstructured":"Hewinson R. G. H. M. Vordermeier and B. M. Buddle. 2003. Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics. Tuberculosis 83 : 119-130.","DOI":"10.1016\/S1472-9792(02)00062-8"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)02166-6"},{"key":"e_1_3_2_22_2","first-page":"775","volume":"58","year":"1983","unstructured":"Kubit, S., S. Czajka, T. Olakowski, and Z. Piasecki. 1983. Evaluation of the effectiveness of BCG vaccinations. Pediatr. Pol.58:775-782.","journal-title":"Pediatr. Pol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.201404898"},{"key":"e_1_3_2_24_2","first-page":"717","volume":"5","year":"2001","unstructured":"Leung, C. C., C. M. Tam, S. L. Chan, M. Chan-Yeung, C. K. Chan, and K. C. Chang. 2001. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Int. J. Tuberc. Lung Dis.5:717-723.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_25_2","first-page":"15","volume":"62","year":"1987","unstructured":"Lugosi, L. 1987. Analysis of the efficacy of mass BCG vaccination from 1959-1983 in tuberculosis control in Hungary: multiple comparison of results. Bull. Int. Union Tuberc. Lung Dis.62:15-34.","journal-title":"Bull. Int. Union Tuberc. Lung Dis."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.4049\/jimmunol.163.4.2249","volume":"163","year":"1999","unstructured":"Marchant, A., T. Goetghebuer, M. O. Ota, I. Wolfe, S. J. Ceesay, D. De Groote, T. Corrah, S. Bennett, J. Wheeler, K. Huygen, P. Aaby, K. P. W. J. McAdam, and M. J. Newport. 1999. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J. Immunol.163:2249-2255.","journal-title":"J. Immunol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00155-4"},{"key":"e_1_3_2_28_2","first-page":"306","volume":"54","year":"2001","unstructured":"Olsen, I., and A. K. Storset. 2001. Innate IFN-\u03b3 production in cattle in response to MPP14, a secreted protein from Mycobacterium avium ssp. paratuberculosis. Scand. J. Immunol.54:306-313.","journal-title":"J. Immunol."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(95)90591-X"},{"key":"e_1_3_2_30_2","first-page":"553","volume":"94","year":"1966","unstructured":"Palmer, C. E., and M. W. Long. 1966. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am. Rev. Respir. Dis.94:553-568.","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-0813.1990.tb07730.x"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(92)90043-J"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(81)90037-4"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.4.9706037"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.3.1706-1709.2000"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.6.3026-3032.2002"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.5.2172-2177.1999"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.10.5809-5815.2000"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1135(92)90142-G"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni832"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.71.11.6411-6419.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.71.11.6411-6419.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T06:45:56Z","timestamp":1682577956000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.71.11.6411-6419.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["10.1128\/IAI.71.11.6411-6419.2003"],"URL":"https:\/\/doi.org\/10.1128\/iai.71.11.6411-6419.2003","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]},"assertion":[{"value":"2003-03-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-08-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}